In clinical trials, retatrutide has shown weight loss exceeding 24% of body weight, surpassing both semaglutide and tirzepatide
Disclaimer: The research articles listed above are for informational purposes only
Emerald Compounding Pharmacys provider onboarding takes providers from application to first prescription in a streamlined, verified process
"With the recent spike in demand surrounding these medications, HR decision-makers feel it will create a better health insurance package overall for employees, as well as boost their mental and physical health long-term," Wantuck told SHRM Online last month, noting that more than two-thirds of companies that added GLP-1s to their health care offerings experienced an increase in enrollment
Harold Bays, medical director of the Louisville Metabolic and Atherosclerosis Research Center
This all means GLP-1 drugs should not be viewed as cholesterol treatment for people who already have normal levels or as a replacement for healthy eating